Financings in Brief: First Medical, Inc.
This article was originally published in The Gray Sheet
Executive Summary
First Medical, Inc.: Development-stage firm completes a $7 mil. round of venture financing. Based in Mountain View, California, privately held First Medical is engaged in developing "clinical decision-making systems which will provide rapid, on-demand (STAT) information to be used for more cost-effective management of patients with potentially life-threatening conditions," the company says. The firm's first initiative is to develop a system for diagnosing myocardial infarction in patients presenting with chest pain. Funds from this offering will enable First Medical to "continue development, and to initiate clinical trials and manufacturing" of the cardiac marker system, the company says. Burr, Egan, Deleage & Co. were lead investors; others participating included Marquette Venture Partners, Piper Jaffray Ventures, InterWest Partners, and Mohr, Davidow Ventures...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.